APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Montelukast Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchMontelukast Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Drug Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Montelukast Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Drug Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Drug Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Montelukast Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Montelukast Drug include Teva, Sandoz, Merck & Co., Mylan, Unimark, Unichem Laboratories, Torrent Pharmaceuticals, Shanghai Anbison Lab and Perrigo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Montelukast Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Montelukast Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Montelukast Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Montelukast Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Montelukast Drug Segment by Company

Teva

Sandoz

Merck & Co.

Mylan

Unimark

Unichem Laboratories

Torrent Pharmaceuticals

Shanghai Anbison Lab

Perrigo

MACLEODS

Lannett Company

Jubilant Pharma

Hikma Group

Hetero

Glenmark Pharmaceuticals

Dr. Reddys Laboratories

CSPC Ouyi Pharmaceutical

Cipla

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Ajanta Pharma

Accord Healthcare

Montelukast Drug Segment by Type

Tablets

Oral Granules

Montelukast Drug Segment by Application

Hospital

Drug Store

Others

Montelukast Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Montelukast Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Montelukast Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Montelukast Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Montelukast Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Montelukast Drug Industry Trends Table 2. Montelukast Drug Industry Drivers Table 3. Montelukast Drug Industry Opportunities and Challenges Table 4. Montelukast Drug Industry Restraints Table 5. Global Montelukast Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Montelukast Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Montelukast Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Montelukast Drug Sales Market Share by Manufacturers Table 9. Global Montelukast Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Montelukast Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Montelukast Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Montelukast Drug Manufacturers, Product Type & Application Table 13. Global Montelukast Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Montelukast Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Oral Granules Table 18. Global Montelukast Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 20. Global Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 21. Global Montelukast Drug Sales Market Share by Type (2021-2026) Table 22. Global Montelukast Drug Sales Market Share by Type (2027-2032) Table 23. Global Montelukast Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Montelukast Drug Revenue by Type (2021-2026) & (W Units) Table 25. Global Montelukast Drug Revenue by Type (2027-2032) & (W Units) Table 26. Global Montelukast Drug Revenue Market Share by Type (2021-2026) Table 27. Global Montelukast Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug Store Table 30. Major Manufacturers of Others Table 31. Global Montelukast Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 33. Global Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 34. Global Montelukast Drug Sales Market Share by Application (2021-2026) Table 35. Global Montelukast Drug Sales Market Share by Application (2027-2032) Table 36. Global Montelukast Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Montelukast Drug Revenue by Application (2021-2026) & (W Units) Table 38. Global Montelukast Drug Revenue by Application (2027-2032) & (W Units) Table 39. Global Montelukast Drug Revenue Market Share by Application (2021-2026) Table 40. Global Montelukast Drug Revenue Market Share by Application (2027-2032) Table 41. Global Montelukast Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Montelukast Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Montelukast Drug Sales Market Share by Region (2021-2026) Table 44. Global Montelukast Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Montelukast Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 48. North America Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 49. Europe Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 51. Europe Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 58. Global Montelukast Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Montelukast Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Montelukast Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Montelukast Drug Revenue Market Share by Region (2021-2026) Table 62. Global Montelukast Drug Revenue Market Share by Region (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Montelukast Drug Product Portfolio Table 67. Teva Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sandoz Montelukast Drug Product Portfolio Table 72. Sandoz Recent Development Table 73. Merck & Co. Company Information Table 74. Merck & Co. Business Overview Table 75. Merck & Co. Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck & Co. Montelukast Drug Product Portfolio Table 77. Merck & Co. Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Montelukast Drug Product Portfolio Table 82. Mylan Recent Development Table 83. Unimark Company Information Table 84. Unimark Business Overview Table 85. Unimark Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Unimark Montelukast Drug Product Portfolio Table 87. Unimark Recent Development Table 88. Unichem Laboratories Company Information Table 89. Unichem Laboratories Business Overview Table 90. Unichem Laboratories Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Unichem Laboratories Montelukast Drug Product Portfolio Table 92. Unichem Laboratories Recent Development Table 93. Torrent Pharmaceuticals Company Information Table 94. Torrent Pharmaceuticals Business Overview Table 95. Torrent Pharmaceuticals Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Torrent Pharmaceuticals Montelukast Drug Product Portfolio Table 97. Torrent Pharmaceuticals Recent Development Table 98. Shanghai Anbison Lab Company Information Table 99. Shanghai Anbison Lab Business Overview Table 100. Shanghai Anbison Lab Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shanghai Anbison Lab Montelukast Drug Product Portfolio Table 102. Shanghai Anbison Lab Recent Development Table 103. Perrigo Company Information Table 104. Perrigo Business Overview Table 105. Perrigo Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Perrigo Montelukast Drug Product Portfolio Table 107. Perrigo Recent Development Table 108. MACLEODS Company Information Table 109. MACLEODS Business Overview Table 110. MACLEODS Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. MACLEODS Montelukast Drug Product Portfolio Table 112. MACLEODS Recent Development Table 113. Lannett Company Company Information Table 114. Lannett Company Business Overview Table 115. Lannett Company Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Lannett Company Montelukast Drug Product Portfolio Table 117. Lannett Company Recent Development Table 118. Jubilant Pharma Company Information Table 119. Jubilant Pharma Business Overview Table 120. Jubilant Pharma Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Jubilant Pharma Montelukast Drug Product Portfolio Table 122. Jubilant Pharma Recent Development Table 123. Hikma Group Company Information Table 124. Hikma Group Business Overview Table 125. Hikma Group Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hikma Group Montelukast Drug Product Portfolio Table 127. Hikma Group Recent Development Table 128. Hetero Company Information Table 129. Hetero Business Overview Table 130. Hetero Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Hetero Montelukast Drug Product Portfolio Table 132. Hetero Recent Development Table 133. Glenmark Pharmaceuticals Company Information Table 134. Glenmark Pharmaceuticals Business Overview Table 135. Glenmark Pharmaceuticals Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Glenmark Pharmaceuticals Montelukast Drug Product Portfolio Table 137. Glenmark Pharmaceuticals Recent Development Table 138. Dr. Reddys Laboratories Company Information Table 139. Dr. Reddys Laboratories Business Overview Table 140. Dr. Reddys Laboratories Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Dr. Reddys Laboratories Montelukast Drug Product Portfolio Table 142. Dr. Reddys Laboratories Recent Development Table 143. CSPC Ouyi Pharmaceutical Company Information Table 144. CSPC Ouyi Pharmaceutical Business Overview Table 145. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio Table 147. CSPC Ouyi Pharmaceutical Recent Development Table 148. Cipla Company Information Table 149. Cipla Business Overview Table 150. Cipla Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Cipla Montelukast Drug Product Portfolio Table 152. Cipla Recent Development Table 153. Aurobindo Pharma Company Information Table 154. Aurobindo Pharma Business Overview Table 155. Aurobindo Pharma Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Aurobindo Pharma Montelukast Drug Product Portfolio Table 157. Aurobindo Pharma Recent Development Table 158. Apotex Company Information Table 159. Apotex Business Overview Table 160. Apotex Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Apotex Montelukast Drug Product Portfolio Table 162. Apotex Recent Development Table 163. Amneal Pharmaceuticals Company Information Table 164. Amneal Pharmaceuticals Business Overview Table 165. Amneal Pharmaceuticals Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Amneal Pharmaceuticals Montelukast Drug Product Portfolio Table 167. Amneal Pharmaceuticals Recent Development Table 168. Ajanta Pharma Company Information Table 169. Ajanta Pharma Business Overview Table 170. Ajanta Pharma Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Ajanta Pharma Montelukast Drug Product Portfolio Table 172. Ajanta Pharma Recent Development Table 173. Accord Healthcare Company Information Table 174. Accord Healthcare Business Overview Table 175. Accord Healthcare Montelukast Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Accord Healthcare Montelukast Drug Product Portfolio Table 177. Accord Healthcare Recent Development Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Montelukast Drug Distributors List Table 181. Montelukast Drug Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Montelukast Drug Product Image Figure 2. Global Montelukast Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Montelukast Drug Sales (2021-2032) & (W Units) Figure 5. Global Montelukast Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Montelukast Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Oral Granules Image Figure 10. Global Montelukast Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Montelukast Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Montelukast Drug Sales Market Share by Type (2021-2032) Figure 13. Global Montelukast Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Montelukast Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Montelukast Drug Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug Store Image Figure 18. Others Image Figure 19. Global Montelukast Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Montelukast Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Montelukast Drug Sales Market Share by Application (2021-2032) Figure 22. Global Montelukast Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Montelukast Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Montelukast Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Montelukast Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Montelukast Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Montelukast Drug Sales Market Share by Country (2021-2032) Figure 39. China Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Montelukast Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Montelukast Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Montelukast Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Montelukast Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Montelukast Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Montelukast Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Montelukast Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Montelukast Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Montelukast Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Montelukast Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Granules
Applications
  • Hospital
  • Drug Store
  • Others
Companies covered
  • Teva
  • Sandoz
  • Merck & Co.
  • Mylan
  • Unimark
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Shanghai Anbison Lab
  • Perrigo
  • MACLEODS
  • Lannett Company
  • Jubilant Pharma
  • Hikma Group
  • Hetero
  • Glenmark Pharmaceuticals
  • Dr. Reddys Laboratories
  • CSPC Ouyi Pharmaceutical
  • Cipla
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Ajanta Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Montelukast Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Montelukast Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Montelukast Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Montelukast Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Montelukast Drug Market Dynamics
  1. 2.1 Montelukast Drug Industry Trends
  2. 2.2 Montelukast Drug Industry Drivers
  3. 2.3 Montelukast Drug Industry Opportunities and Challenges
  4. 2.4 Montelukast Drug Industry Restraints
3 Montelukast Drug Market by Manufacturers
  1. 3.1 Global Montelukast Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Montelukast Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Montelukast Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Montelukast Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Montelukast Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Montelukast Drug Manufacturers, Product Type & Application
  7. 3.7 Global Montelukast Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Montelukast Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Montelukast Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Montelukast Drug Tier 1, Tier 2, and Tier 3
4 Montelukast Drug Market by Type
  1. 4.1 Montelukast Drug Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Oral Granules
  4. 4.2 Global Montelukast Drug Sales by Type
  5. 4.2.1 Global Montelukast Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Montelukast Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Montelukast Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Montelukast Drug Revenue by Type
  9. 4.3.1 Global Montelukast Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Montelukast Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Montelukast Drug Revenue Market Share by Type (2021-2032)
5 Montelukast Drug Market by Application
  1. 5.1 Montelukast Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.1.3 Others
  5. 5.2 Global Montelukast Drug Sales by Application
  6. 5.2.1 Global Montelukast Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Montelukast Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Montelukast Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Montelukast Drug Revenue by Application
  10. 5.3.1 Global Montelukast Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Montelukast Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Montelukast Drug Revenue Market Share by Application (2021-2032)
6 Global Montelukast Drug Sales by Region
  1. 6.1 Global Montelukast Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Montelukast Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Montelukast Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Montelukast Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Montelukast Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Montelukast Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Montelukast Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Montelukast Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Montelukast Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Montelukast Drug Revenue by Region
  1. 7.1 Global Montelukast Drug Revenue by Region
  2. 7.1.1 Global Montelukast Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Montelukast Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Montelukast Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Montelukast Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Montelukast Drug Revenue (2021-2032)
  8. 7.2.2 North America Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Montelukast Drug Revenue (2021-2032)
  11. 7.3.2 Europe Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Montelukast Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Montelukast Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Montelukast Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Montelukast Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Montelukast Drug Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Merck & Co.
  14. 8.3.1 Merck & Co. Company Information
  15. 8.3.2 Merck & Co. Business Overview
  16. 8.3.3 Merck & Co. Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co. Montelukast Drug Product Portfolio
  18. 8.3.5 Merck & Co. Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Montelukast Drug Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Unimark
  26. 8.5.1 Unimark Company Information
  27. 8.5.2 Unimark Business Overview
  28. 8.5.3 Unimark Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Unimark Montelukast Drug Product Portfolio
  30. 8.5.5 Unimark Recent Developments
  31. 8.6 Unichem Laboratories
  32. 8.6.1 Unichem Laboratories Company Information
  33. 8.6.2 Unichem Laboratories Business Overview
  34. 8.6.3 Unichem Laboratories Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Unichem Laboratories Montelukast Drug Product Portfolio
  36. 8.6.5 Unichem Laboratories Recent Developments
  37. 8.7 Torrent Pharmaceuticals
  38. 8.7.1 Torrent Pharmaceuticals Company Information
  39. 8.7.2 Torrent Pharmaceuticals Business Overview
  40. 8.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Torrent Pharmaceuticals Montelukast Drug Product Portfolio
  42. 8.7.5 Torrent Pharmaceuticals Recent Developments
  43. 8.8 Shanghai Anbison Lab
  44. 8.8.1 Shanghai Anbison Lab Company Information
  45. 8.8.2 Shanghai Anbison Lab Business Overview
  46. 8.8.3 Shanghai Anbison Lab Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Anbison Lab Montelukast Drug Product Portfolio
  48. 8.8.5 Shanghai Anbison Lab Recent Developments
  49. 8.9 Perrigo
  50. 8.9.1 Perrigo Company Information
  51. 8.9.2 Perrigo Business Overview
  52. 8.9.3 Perrigo Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Perrigo Montelukast Drug Product Portfolio
  54. 8.9.5 Perrigo Recent Developments
  55. 8.10 MACLEODS
  56. 8.10.1 MACLEODS Company Information
  57. 8.10.2 MACLEODS Business Overview
  58. 8.10.3 MACLEODS Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MACLEODS Montelukast Drug Product Portfolio
  60. 8.10.5 MACLEODS Recent Developments
  61. 8.11 Lannett Company
  62. 8.11.1 Lannett Company Company Information
  63. 8.11.2 Lannett Company Business Overview
  64. 8.11.3 Lannett Company Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lannett Company Montelukast Drug Product Portfolio
  66. 8.11.5 Lannett Company Recent Developments
  67. 8.12 Jubilant Pharma
  68. 8.12.1 Jubilant Pharma Company Information
  69. 8.12.2 Jubilant Pharma Business Overview
  70. 8.12.3 Jubilant Pharma Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jubilant Pharma Montelukast Drug Product Portfolio
  72. 8.12.5 Jubilant Pharma Recent Developments
  73. 8.13 Hikma Group
  74. 8.13.1 Hikma Group Company Information
  75. 8.13.2 Hikma Group Business Overview
  76. 8.13.3 Hikma Group Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hikma Group Montelukast Drug Product Portfolio
  78. 8.13.5 Hikma Group Recent Developments
  79. 8.14 Hetero
  80. 8.14.1 Hetero Company Information
  81. 8.14.2 Hetero Business Overview
  82. 8.14.3 Hetero Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hetero Montelukast Drug Product Portfolio
  84. 8.14.5 Hetero Recent Developments
  85. 8.15 Glenmark Pharmaceuticals
  86. 8.15.1 Glenmark Pharmaceuticals Company Information
  87. 8.15.2 Glenmark Pharmaceuticals Business Overview
  88. 8.15.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Glenmark Pharmaceuticals Montelukast Drug Product Portfolio
  90. 8.15.5 Glenmark Pharmaceuticals Recent Developments
  91. 8.16 Dr. Reddys Laboratories
  92. 8.16.1 Dr. Reddys Laboratories Company Information
  93. 8.16.2 Dr. Reddys Laboratories Business Overview
  94. 8.16.3 Dr. Reddys Laboratories Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Dr. Reddys Laboratories Montelukast Drug Product Portfolio
  96. 8.16.5 Dr. Reddys Laboratories Recent Developments
  97. 8.17 CSPC Ouyi Pharmaceutical
  98. 8.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 8.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 8.17.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio
  102. 8.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 8.18 Cipla
  104. 8.18.1 Cipla Company Information
  105. 8.18.2 Cipla Business Overview
  106. 8.18.3 Cipla Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cipla Montelukast Drug Product Portfolio
  108. 8.18.5 Cipla Recent Developments
  109. 8.19 Aurobindo Pharma
  110. 8.19.1 Aurobindo Pharma Company Information
  111. 8.19.2 Aurobindo Pharma Business Overview
  112. 8.19.3 Aurobindo Pharma Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aurobindo Pharma Montelukast Drug Product Portfolio
  114. 8.19.5 Aurobindo Pharma Recent Developments
  115. 8.20 Apotex
  116. 8.20.1 Apotex Company Information
  117. 8.20.2 Apotex Business Overview
  118. 8.20.3 Apotex Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Apotex Montelukast Drug Product Portfolio
  120. 8.20.5 Apotex Recent Developments
  121. 8.21 Amneal Pharmaceuticals
  122. 8.21.1 Amneal Pharmaceuticals Company Information
  123. 8.21.2 Amneal Pharmaceuticals Business Overview
  124. 8.21.3 Amneal Pharmaceuticals Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Amneal Pharmaceuticals Montelukast Drug Product Portfolio
  126. 8.21.5 Amneal Pharmaceuticals Recent Developments
  127. 8.22 Ajanta Pharma
  128. 8.22.1 Ajanta Pharma Company Information
  129. 8.22.2 Ajanta Pharma Business Overview
  130. 8.22.3 Ajanta Pharma Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Ajanta Pharma Montelukast Drug Product Portfolio
  132. 8.22.5 Ajanta Pharma Recent Developments
  133. 8.23 Accord Healthcare
  134. 8.23.1 Accord Healthcare Company Information
  135. 8.23.2 Accord Healthcare Business Overview
  136. 8.23.3 Accord Healthcare Montelukast Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Accord Healthcare Montelukast Drug Product Portfolio
  138. 8.23.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Montelukast Drug Value Chain Analysis
  2. 9.1.1 Montelukast Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Montelukast Drug Production Mode & Process
  6. 9.2 Montelukast Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Montelukast Drug Distributors
  9. 9.2.3 Montelukast Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst